Stifel Nicolaus Sticks to Their Buy Rating for Alkermes (ALKS)
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alkermes (ALKS – Research Report) today and set a price target of $36.00. The ...
Stifel Nicolaus Reaffirms Their Buy Rating on Disc Medicine (IRON)
In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Disc Medicine (IRON – Research Report), with a ...
yr.no2d
Grand Isle
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...